Figure 1.
Trend of prevalence of use of study medications during follow-up
Abbreviations: ACE, angiotensin-converting enzyme inhibitor; ARB, antiotensin-II receptor blocker; BB, beta-blockers; STN, statins; CLOP, clopidogrel.
Trend of prevalence of use of study medications during follow-up
Abbreviations: ACE, angiotensin-converting enzyme inhibitor; ARB, antiotensin-II receptor blocker; BB, beta-blockers; STN, statins; CLOP, clopidogrel.